Chemed Co. (NYSE:CHE) announced a quarterly dividend on Friday, February 16th, RTT News reports. Shareholders of record on Monday, February 26th will be given a dividend of 0.28 per share on Monday, March 19th. This represents a $1.12 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Friday, February 23rd.
Chemed has raised its dividend by an average of 8.7% per year over the last three years and has raised its dividend annually for the last 9 consecutive years. Chemed has a payout ratio of 23.7% indicating that its dividend is sufficiently covered by earnings.
Shares of Chemed (NYSE CHE) opened at $256.56 on Thursday. Chemed has a 12-month low of $175.60 and a 12-month high of $275.83. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.88 and a current ratio of 0.91. The firm has a market capitalization of $4,093.20, a PE ratio of 44.16 and a beta of 1.13.
Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, February 14th. The company reported $2.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.05. Chemed had a return on equity of 30.04% and a net margin of 5.89%. The business had revenue of $428.35 million for the quarter, compared to the consensus estimate of $423.83 million. During the same quarter last year, the business posted $2.10 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis.
A number of research firms have weighed in on CHE. Oppenheimer raised their price target on Chemed from $270.00 to $275.00 and gave the company an “outperform” rating in a research report on Friday, February 16th. ValuEngine downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Zacks Investment Research upgraded Chemed from a “hold” rating to a “buy” rating and set a $251.00 price target on the stock in a research report on Thursday, November 2nd. Royal Bank of Canada restated a “hold” rating and set a $258.00 price target on shares of Chemed in a research report on Friday, February 16th. Finally, TheStreet upgraded Chemed from a “c+” rating to an “a-” rating in a research report on Friday, October 27th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Chemed presently has a consensus rating of “Hold” and an average price target of $261.33.
In other news, VP Naomi C. Dallob sold 950 shares of Chemed stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $240.38, for a total value of $228,361.00. Following the transaction, the vice president now owns 9,747 shares in the company, valued at $2,342,983.86. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider David Patrick Williams sold 11,000 shares of Chemed stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $241.28, for a total value of $2,654,080.00. Following the completion of the transaction, the insider now owns 74,857 shares in the company, valued at approximately $18,061,496.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,000 shares of company stock worth $3,402,291. Company insiders own 4.90% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Chemed Co. (CHE) Declares Quarterly Dividend of $0.28” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/22/chemed-co-che-declares-quarterly-dividend-of-0-28.html.
Chemed Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.